Palmitoyl Tetrapeptide-20

Functions
Repigmenting
Hair-coloring
Antioxidant
INCI name
Palmitoyl Tetrapeptide-20

Palmitoyl Tetrapeptide-20 is a biomimetic lipo-peptide with sequence Pal-His-Phe-Arg-Trp-NH2 that mimics α-MSH (alpha Melanocyte Stimulating Hormone) by binding the MC1-R (melanocortin 1 receptor) and stimulating melanin production. It is known under the trade name Greyverse™. Its sequence (His-Phe-Arg-Trp or HFRW) repeats in Pro-opiomelanocortin three times.

Incorporated in hair care applications, Palmitoyl Tetrapeptide-20 speeds up melanosome maturation in follicular melanocytes and their transfer to keratinocytes, preventing and reversing (re-pigmentation) hair greying. It restores natural hair color at relatively higher concentrations, which can be supported by preventive applications containing lower concentrations.

In addition, Palmitoyl Tetrapeptide-20 enhances the expression of catalase, an antioxidant enzyme responsible for intracellular oxygen peroxide destruction. It lessens intracellular H2O2 by up to 30%, preventing oxidative stress and cell damage.

Palmitoyl Tetrapeptide-20 is an effective, safe, and scalp-friendly ingredient for hair,  beard, and mustache care applications. It is an ideal alternative to chemical coloring that progressively restores natural hair color, revealing a youthful hair appearance.
Synonyms
Greyverse™
Changed

References

Reversal of Premature Hair Graying Treated with a Topical Formulation Containing α-Melanocyte-Stimulating Hormone Agonist (Greyverse Solution 2%)
Author(s):
PMID:
37034550
DOI:
10.4103/ijt.ijt_85_22
Single Nucleotide Polymorphisms in the Melanocortin His-Phe-Arg-Trp Sequences Decrease Tetrapeptide Potency and Efficacy
Author(s):
, , ,
PMID:
32184956
DOI:
10.1021/acsmedchemlett.9b00198
Reversal of Premature Hair Graying Treated with a Topical Formulation Containing α-Melanocyte-Stimulating Hormone Agonist (Greyverse Solution 2%)
Author(s):
PMID:
37034550
DOI:
10.4103/ijt.ijt_85_22
Pro-opiomelanocortin (P01189 · COLI_HUMAN; POMC)
Author(s):
Reversal of Premature Hair Graying Treated with a Topical Formulation Containing α-Melanocyte-Stimulating Hormone Agonist (Greyverse Solution 2%)
Author(s):
DOI:
10.4103/ijt.ijt_85_22